Anticoagulant effects of dabigatran
Anticoagulant Effects of Dabigatran on Atrial Fibrillation
Atrial fibrillation is a heart condition characterized by rapid, irregular, and often uncoordinated contractions of the atria and results in an inability to pump blood effectively. As a result, those with this condition are at risk for developing blood clots which, if untreated, can cause a stroke. One way to help reduce the risk of stroke for those with atrial fibrillation is through anticoagulation; the use of blood thinners like dabigatran. Dabigatran is a direct thrombin (Factor IIa) inhibitor that has been found to be as effective as warfarin in reducing the risk of stroke, but with fewer drug interactions and more predictable anticoagulant effects.
Research indicates several benefits of dabigatran for those with atrial fibrillation, including:
- Fewer drug interactions – Dabigatran does not interact with other drugs in the same manner as warfarin and is less affected by changes in diet, interactions with other drugs, or alcohol use.
- Reduced risk of thromboembolism – Studies have shown dabigatran to be as effective as warfarin in reducing the risk of thromboembolic events (clots) in patients with atrial fibrillation.
- Reduced risk of bleeding – Dabigatran is less likely to cause bleeding than warfarin and has fewer adverse effects on the body.
- Improved availability, cost, and convenience – Since dabigatran is available in pill form, it is convenient, easier to track dosage, and can be acquired for a lower cost than warfarin.
Despite the benefits of dabigatran, it is important for patients with atrial fibrillation to continue to follow all medical advice for their condition, including regular monitoring of blood clotting and consulting with their doctor if they experience any side effects.